Breakthrough inflammatory disease treatment set for commercial spin-out
Scottish funding marks a major milestone in the creation of treatment for millions of sufferers of chronic inflammatory diseases
Scottish funding marks a major milestone in the creation of treatment for millions of sufferers of chronic inflammatory diseases
The technology extends capabilities in column performance for biopharma and proteomics researchers
Watch this free on-demand webinar to discover how headspace analytical methods are being utilized in the detection of volatile biomarkers
Which new products helped to accelerate your lab work this year?
Gain insights on a range of current topics, including clinical microbiology, vaccine design, cell viability and more
Diadem announces publication of clinical data showing its AlzoSure biomarker test is able to predict progression to Alzheimer’s disease years before symptoms are displayed.
Introduced at AACC, the VeraPrep Antibody Detection Kit enables researchers to measure antibodies against any antigen of interest in serum, plasma or saliva
Two new studies reveal how antibodies against the SARS-CoV-2 virus can vary between individuals
Gain insights on topics from point-of-care blood testing, cardiac troponin and biomarker discovery to clinical QC and more
Watch world-leading scientists online, October 5, to discover the latest tools and techniques advancing Alzheimer's research, single cell characterization, biomarker discovery and more
How scientists at Kato Pharmaceuticals have expanded from early-stage development to biopharmaceutical production of clinical drug products
Watch this on-demand webinar to explore a complete workflow for the development of targeted biomarker measurements for precision medicine
Using cancer biomarkers, the VENTANA MMR RxDx Panel helps determine which tumor patients may benefit from GSK immunotherapy
Gain insights on topics from point-of-care cardiac troponin, CRISPR editing efficiency, targeted biomarker measurements for precision medicine & more
Sengenics CSO and inventor of the KREX™ protein folding technology, Professor Jonathan Blackburn, discusses the applications of KREX™ for the discovery of autoantibody-based companion diagnostics and early disease detection biomarkers, as well as the potential benefits in the treatment of autoimmune disease, cancer, neurological and infectious diseases and beyond
Ligand-based technologies integrated into Flare V5 offer a comprehensive molecule design solution for drug discovery research chemists
Register free today to join scientists from around the world as they come together to discuss the hottest topics and latest technology solutions